Advertisement

Topics

Molecular Diagnostics Market by Application Infectious Disease HIV, HPV, TB, Oncology, Genetics, Microbiology, Technology PCR, Microarray, DNA Sequencing, End User Hospital, Laboratories, Product Instruments, Reagent, Software Forecast to 2020 Prices fro

17:51 EST 22 Feb 2017 | BioPortfolio Reports

The molecular diagnostics market is estimated to grow at a CAGR of 9.3% to reach USD 9,333.8 million by 2020.
In this report, the molecular diagnostics market is broadly segmented on the basis of technologies, applications, products services, and end users. On the basis of technology, the market is segmented into PCR, INAAT, microarrays, hybridization, DNA sequencing and nextgeneration sequencing NGS, and other technologies. Among these technologies, PCR is expected to command the largest share while microarrays is expected to grow at the highest rate.

The molecular diagnostics market, by application, is classified into infectious diseases, oncology, genetics, blood screening, microbiology, and others cardiovascular diseases, neurological diseases, DNA fingerprinting, tissue typing, and food pathogen detection testing. The infectious diseases segment will account for the largest share of the global molecular diagnostics market in 2015, followed by the blood screening and oncology segments.
On the basis of products and services, the molecular diagnostics market is segmented into instruments, reagents, and services software. The reagents segment is expected to account for the largest share and highest CAGR of the molecular diagnostics market in 2015.
Based on end users, the market is segmented into hospital academic laboratories, reference laboratories, and others blood banks, local public health laboratories, home health agencies, nursing homes, pointofcare settings, and selftesting. As most diagnostic tests are carried out inhouse, the hospital academic laboratories segment is expected to dominate the market. On the other hand, newly launched, complex, and highly specialized tests are mostly offered only at a few large reference laboratories, owing to which the reference laboratories segment is expected to grow at the highest rate during the forecast period.
The major factors driving this market are high prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of biomarkers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system. However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the molecular diagnostics market.

Major players operating in the molecular diagnostics market are Roche Diagnostics U.S., QIAGEN N.V. Netherlands, Hologic Inc. U.S., Grifols Spain, Abbott Laboratories U.S., Siemens Healthcare Germany, Becton, Dickinson and Company U.S., Beckman Coulter Inc. U.S., bioMrieux SA France, and Cepheid Inc. U.S..

Scope of the Report
This market study majorly covers the products and services, applications, technologies, and end users for arriving at the overall molecular diagnostics market size in the period from 2015 to 2020.
Years Considered for the Study



Market Segmentation
Molecular Diagnostics Market, by Products and Services
Instruments
Reagents
Services Software

Molecular Diagnostics Market, by Technology
Polymerase Chain Reaction PCR
Isothermal Nucleic Acid Amplification Technology INAAT
Hybridization [In Situ Hybridization Fluorescent In Situ Hybridization FISH]
DNA Sequencing and Nextgeneration Sequencing
Microarrays
Others Mass Spectrometry, Flow Cytometry, and Electrophoresis

Molecular Diagnostics Market, by Application
Infectious Diseases
Oncology
Genetics
Blood Screening
Microbiology
Others Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting

Molecular Diagnostics Market, by End User
Reference Laboratories
Hospital Laboratories
Others Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Pointofcare Settings, and Selftesting
Molecular Diagnostics Market, by Region
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe RoE
Asia
Japan
India
China
Rest of Asia RoA
Rest of the World RoW
Latin America
o Brazil
o Mexico
o Rest of Latin America RoLA
Pacific Countries
Middle East Africa

Original Article: Molecular Diagnostics Market by Application Infectious Disease HIV, HPV, TB, Oncology, Genetics, Microbiology, Technology PCR, Microarray, DNA Sequencing, End User Hospital, Laboratories, Product Instruments, Reagent, Software Forecast to 2020 Prices fro

NEXT ARTICLE

More From BioPortfolio on "Molecular Diagnostics Market by Application Infectious Disease HIV, HPV, TB, Oncology, Genetics, Microbiology, Technology PCR, Microarray, DNA Sequencing, End User Hospital, Laboratories, Product Instruments, Reagent, Software Forecast to 2020 Prices fro"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Polymerase Chain Reaction (PCR)
PCR (Polymerase Chain Reaction) uses the ability of DNA polymerase (enzymes that create DNA molecules by assembling nucleotides, the building blocks of DNA. These enzymes are essential to DNA replication and usually work in pairs to create two ident...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...